When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 18 Mar 2025
Last updated: 04 Mar 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • age 20 to 34 years
  • testicular mass

Other diagnostic factors

  • extratesticular manifestation

Risk factors

  • cryptorchidism
  • gonadal dysgenesis
  • family history of testicular cancer
  • personal history of testicular cancer
  • testicular atrophy
  • white ethnicity
  • HIV infection
  • occupational exposures
  • inguinal hernia
  • genetic abnormality

Diagnostic investigations

1st investigations to order

  • ultrasound with colour Doppler of testis
  • chest imaging
  • CT scan abdomen and pelvis with contrast
  • serum beta-human chorionic gonadotrophin (beta-hCG)
  • serum alpha-fetoprotein (AFP)
  • serum lactate dehydrogenase (LDH)
  • histological examination of testicular mass post-orchiectomy

Investigations to consider

  • serum placental alkaline phosphatase
  • MRI abdomen and pelvis
  • CT scan chest
  • biopsy of contralateral testis

Treatment algorithm

Contributors

Authors

Al B. Barqawi, MD, FRCS

Professor of Surgery/Urology

University of Colorado Anschutz Medical Campus

Aurora

CO

Disclosures

ABB declares that he has no competing interests.

Corbin J. Eule, MD

Assistant Professor of Medical Oncology

University of Colorado Anschutz Medical Campus

Aurora

CO

Disclosures

CJE declares that he has no competing interests.

Acknowledgements

Dr Al B. Barqawi and Dr Corbin J. Eule would like to gratefully acknowledge Dr Elizabeth R. Kessler, Dr Thomas W. Flaig, and Dr Brandon Bernard, previous contributors to this topic.

Disclosures

ERK, TWF, and BB declare that they have no competing interests.

Peer reviewers

Elisabeth Heath, MD

Assistant Professor of Medicine and Oncology

Karmanos Cancer Institute

Wayne State University

Detroit

MI

Disclosures

EH declares that she has no competing interests.

Gianfilippo Bertelli, MD, PhD, FRCP (Edin)

Consultant/Honorary Senior Lecturer in Medical Oncology

SW Wales Cancer Institute/Department of Oncology

Singleton Hospital

Sketty

Swansea

UK

Disclosures

GB declares that he has no competing interests.

Emilio Porfiri, MD, PhD

Senior Lecturer in Medical Oncology

School of Cancer Sciences

University of Birmingham

Birmingham

UK

Disclosures

EP declares that he has no competing interests.

Use of this content is subject to our disclaimer